ClinicalTrials.gg
RecruitingNCT05968807Updated Nov 19, 2026

iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients

An interventional study of iParent2Parent Program in Solid Organ Transplant, sponsored by The Hospital for Sick Children. Recruiting at 1 site in Canada. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by The Hospital for Sick Children · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Aug 2023; still recruiting 3 years 3 months later.
Updated Nov 19, 2026Study completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
55
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The iParent2Parent (iP2P) program is a new, innovative virtual mentorship program that will connect parents one-to-one with other parents of pediatric solid organ transplant (SOT) recipients who are trained to offer vital peer support and mentorship. Parents of children who received a SOT at The Hospital for Sick Children will be invited to participate as mentors and mentees (randomized into the iP2P or control group). The iP2P program can decrease feelings of isolation, improve mental health and have a long-term positive impact on patient health. This research will increase our understanding of one-to-one peer support and leverage eHealth technologies to improve the access to and acceptability of parent peer support interventions.

02

Conditions studied

  • Solid Organ Transplant

Keywords

  • Peer Support Mentorship
  • Parent Support Mentorship
  • Pediatrics
  • Transplant
03

In context

Lead sponsor

The Hospital for Sick Children is the lead sponsor of 579 studies on the registry; 81 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Mentee Inclusion Criteria:

  • Parent of a patient under 18 years of age who received a solid organ transplant and is at least two months post-transplant,
  • Access to a device (e.g., smart phone, tablet, computer) capable of using free WhatsApp software, and
  • English-speaking.

Mentor Inclusion Criteria:

  • Parent of a patient under 21 years of age who received a solid organ transplant and is at least one year post-transplant,
  • Nominated by their child's healthcare team as a good candidate to act in the mentor role (e.g., good communication skills, positive adaptation and adjustment post-transplant, strong support network),
  • Access to a device (e.g., smart phone, tablet, computer) capable of using free WhatsApp software, and
  • English-speaking.

Exclusion Criteria:

  • Non-English speaking.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
55 participants (estimated)

Study arms

  • Experimental
    iParent2Parent Program

    Behavioral: iParent2Parent Program

  • No intervention
    Standard of Care Waitlist Control Group

Interventions

  • BehavioraliParent2Parent Program

    iParent2Parent is an online peer support mentorship program that is based on the iPeer2Peer online peer support mentorship program, which has been established in multiple chronic disease populations as a self-management intervention, including in chronic pain and juvenile idiopathic arthritis populations. The iParent2Parent program connect parents one-to-one with other parents of pediatric solid organ transplant (SOT) recipients who are trained to offer vital peer support and mentorship.

06

What researchers measure

Primary outcomes

  1. Recruitment rates and withdrawal rates

    How many participants were recruited and have withdrawn from the program on average over time.

    Time frame: Baseline to study completion, an average of 1 year

  2. Adherence with the iParent2Parent program

    When the participant completes 10 audio or video calls over 12 weeks and 100% when all online outcome measures completed.

    Time frame: Baseline to study completion, an average of 1 year

  3. Acceptability (Mentees)

    Whether the innovation is agreeable, palatable or satisfactory. Measured via semi-structured interview or focus group.

    Time frame: Baseline to 12 weeks after baseline/immediately after the intervention

  4. Acceptability (Mentors)

    Whether the innovation is agreeable, palatable or satisfactory. Measured via semi-structured interview or focus group.

    Time frame: Baseline to program completion, an average of one year

  5. Level of engagement with the iParent2Parent program (Mentees)

    Measured via semi-structured interview or focus group.

    Time frame: Baseline to 12 weeks after baseline/immediately after the intervention

  6. Level of engagement with the iParent2Parent program (Mentors)

    Measured via semi-structured interview or focus group.

    Time frame: Baseline to program completion, an average of one year

  7. Barriers and enablers of the iParent2Parent program (Mentees)

    Measured via semi-structured interview or focus group.

    Time frame: Baseline to 12 weeks after baseline/immediately after the intervention

  8. Barriers and enablers of the iParent2Parent program (Mentors)

    Measured via semi-structured interview or focus group.

    Time frame: Baseline to program completion, an average of one year

Secondary outcomes

  1. Parenting stress (Mentees and Mentors)

    Parental Stress Scale; 18-item questionnaire. Each question is scored on a scale from 1 to 5, with scores ranging from 18 to 90. An overall higher score means a worse outcome.

    Time frame: Baseline to program completion, an average of one year

  2. Psychological distress (Mentees and Mentors)

    General Anxiety Disorder-7; 7-item questionnaire. Each question is scored on a scale from 0 to 3, with scores ranging from 0 to 21. An overall higher score means a worse outcome.

    Time frame: Baseline to program completion, an average of one year

  3. Psychological distress (Mentees and Mentors)

    Patient Health Questionnaire Depression Scale; 8-item questionnaire. Each question is scored on a scale from 0 to 3, with scores ranging from 0 to 24. An overall higher score means a worse outcome.

    Time frame: Baseline to program completion, an average of one year

  4. Perceived social support (Mentees and Mentors)

    Short form version 2.0 of the PROMIS battery for: Social Isolation; 6-item questionnaire. Each question is scored on a scale from 1 to 5 and generates a T-score. An overall higher score means a worse outcome.

    Time frame: Baseline to program completion, an average of one year

  5. Perceived social support (Mentees and Mentors)

    Short form version 2.0 of the PROMIS battery for: Informational Support; 6-item questionnaire. Each question is scored on a scale from 1 to 5 and generates a T-score. An overall higher score means a better outcome.

    Time frame: Baseline to program completion, an average of one year

  6. Perceived social support (Mentees and Mentors)

    Short form version 2.0 of the PROMIS battery for: Emotional Support; 6-item questionnaire. Each question is scored on a scale from 1 to 5 and generates a T-score. An overall higher score means a better outcome.

    Time frame: Baseline to program completion, an average of one year

  7. Coping (Mentees and Mentors)

    Coping Health Inventory for Parents; 16-item questionnaire. Each question about coping behaviour is scored on a scale from 0 to 3, with a possible response of "Did not use" the coping behaviour. Scores range from 0 to 48. An overall higher score means a better outcome.

    Time frame: Baseline to program completion, an average of one year

  8. Family Functioning (Mentees and Mentors)

    Pediatric Quality of Life Inventory™ 2.0 Family Impact Module; 36-item questionnaire with 8 different sections: Physical Functioning, Emotional Functioning, Social Functioning, Cognitive Functioning, Communication, Worry, Daily Activities, and Family Relationships. Each question is scored on a scale from 0 to 4. Items are reverse-scored and linearly transformed to a 0-100 scale. An overall higher score means a better outcome.

    Time frame: Baseline to program completion, an average of one year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Aug 2023 to primary completion in Jun 2026, 34 months.

Completion moved once since we started tracking on Sep 25, 2026: Jun 2026 → Mar 2027, on Nov 19, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 29, 2023
First posted
Aug 1, 2023
StartActual
Aug 1, 2023
Primary completionActual
Jun 26, 2026
CompletionEst.
Mar 31, 2027was Jun 2026
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Study completion
Jun 26, 2026→Mar 31, 2027
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Study completion Jun 26, 2026→Mar 31, 2027
    + 3 other changes: verification date, oversight details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05968807
Responsible party
Samantha Anthony (Principal Investigator, The Hospital for Sick Children) — Principal investigator
First posted
Aug 1, 2023
Start date
Aug 1, 2023
Primary completion
Jun 26, 2026
Completion
Mar 31, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Samantha J. Anthony, PhD, MSW
Contact
samantha.anthony@sickkids.ca
416-813-7654 ext. 303126
Sophie Bui, BHSc
Contact
sophie.bui@sickkids.ca
Samantha J. Anthony, PhD, MSW
principal investigator · The Hospital for Sick Children

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion